Teleflex Incorporated (TFX)
NYSE: TFX · Real-Time Price · USD
127.00
+2.04 (1.63%)
At close: Jun 18, 2026, 4:00 PM EDT
125.00
-2.00 (-1.57%)
After-hours: Jun 18, 2026, 7:19 PM EDT
Teleflex Revenue
Teleflex had revenue of $548.26M in the quarter ending March 31, 2026, with 32.35% growth. This brings the company's revenue in the last twelve months to $1.29B, down -44.05% year-over-year. In the year 2025, Teleflex had annual revenue of $1.99B with 17.25% growth.
Revenue (ttm)
$1.29B
Revenue Growth
-44.05%
P/S Ratio
2.64
Revenue / Employee
$137,208
Employees
15,500
Market Cap
5.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.99B | 293.16M | 17.25% |
| Dec 31, 2024 | 1.70B | -12.89M | -0.75% |
| Dec 31, 2023 | 1.71B | -1.08B | -38.65% |
| Dec 31, 2022 | 2.79B | -18.52M | -0.66% |
| Dec 31, 2021 | 2.81B | 272.40M | 10.74% |
| Dec 31, 2020 | 2.54B | -58.20M | -2.24% |
| Dec 31, 2019 | 2.60B | 146.98M | 6.00% |
| Dec 31, 2018 | 2.45B | 302.08M | 14.07% |
| Dec 31, 2017 | 2.15B | 278.27M | 14.90% |
| Dec 31, 2016 | 1.87B | 58.34M | 3.22% |
| Dec 31, 2015 | 1.81B | -30.14M | -1.64% |
| Dec 31, 2014 | 1.84B | 143.56M | 8.46% |
| Dec 31, 2013 | 1.70B | 145.26M | 9.37% |
| Dec 31, 2012 | 1.55B | 58.48M | 3.92% |
| Dec 31, 2011 | 1.49B | 94.81M | 6.78% |
| Dec 31, 2010 | 1.40B | -37.17M | -2.59% |
| Dec 31, 2009 | 1.43B | -477.19M | -24.96% |
| Dec 31, 2008 | 1.91B | 337.00M | 21.40% |
| Dec 31, 2007 | 1.58B | -115.73M | -6.84% |
| Dec 31, 2006 | 1.69B | 128.94M | 8.26% |
| Dec 31, 2005 | 1.56B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baxter International | 11.32B |
| Avantor | 6.55B |
| Bausch + Lomb | 5.21B |
| AptarGroup | 3.87B |
| MiniMed Group | 3.10B |
| Envista Holdings | 2.81B |
| ICU Medical | 2.16B |
| Merit Medical Systems | 1.54B |
TFX News
- 9 days ago - Teleflex’s Freesolve RMS shows long-term safety in four-year study - TheFly
- 9 days ago - Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G) - Business Wire
- 10 days ago - Teleflex upgraded to Overweight from Neutral at Piper Sandler - TheFly
- 17 days ago - Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering - Business Wire
- 17 days ago - Teleflex announces private offering of $500M of senior notes - TheFly
- 17 days ago - Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032 - Business Wire
- 4 weeks ago - Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer - Business Wire
- 4 weeks ago - Teleflex Announces Quarterly Dividend - Business Wire